The Cancer Research UK (CRUK) Barts Centre, a partnership between Queen Mary University of London's Barts Cancer Institute and Centre for Prevention, Detection and Diagnosis at the Wolfson Institute of Population Health, Barts Health NHS Trust and CRUK, is part of a national network of 15 centres. Along with UCL, KCL and the Francis Crick Institute, the CRUK Barts Centre is a key partner in the CRUK City of London Centre, a world-leading hub dedicated to cancer biotherapeutics.
Under the leadership of the Director, Professor Nicholas Lemoine, our vision is to focus on the application and translation of our research to the clinic, whilst continuing to conduct cutting edge, fundamental research to understand the mechanisms that drive tumourigenesis as well as the epidemiology, screening and prevention of cancer.
We have over 350 research staff and 100 graduate students who focus their efforts on how to reduce the burden of disease through prevention; increase the chances of survival through early detection and diagnosis; and improve patient survival through the discovery and development of more effective and innovative therapies.
We place a special emphasis on cancers of unmet need (lung, pancreas, oesophageal, ovarian and triple-negative breast cancers) throughout our research themes, where our breadth of expertise, from basic science to clinical trials, is evident.
We aim to develop a comprehensive understanding of the biology of the disease and translate our discoveries into new approaches to prevent and treat cancer more effectively. We are actively investigating screening and early diagnostics for these cancer types.
We also use our expertise to teach and educate students and professionals about the science of and gold-standard clinical approaches to cancer, and to engage our local population. Our excellence in clinical practice and research provides the best environment to train the next cadre of cancer clinicians and researchers.